USAID Cure Tuberculosis Project Summary of Final Results

Cure Tuberculosis was a five-year activity (2019-2024) implemented by JSI in partnership with University Research Co., LLC (URC) and United States Pharmacopeia (USP), which strengthened the Kyrgyz government’s ability to diagnose, treat, and cure people with drug-resistant tuberculosis (DR-TB). The project activities were aligned with the USAID Global TB Strategy and TB Roadmap implementation pillars: Reach, Cure, Prevent, Innovate, and Sustain. This document highlights the project's final results.